diltiazem has been researched along with dantrolene in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, I; Kimura, M; Maekawa, M | 1 |
| Raij, L; Shultz, PJ | 1 |
| Higham, S; Kraus-Friedmann, N; Pressley, TA; Shoshan-Barmatz, V | 1 |
| Denborough, MA; Foster, PS; Hopkinson, KC | 1 |
| Denborough, MA; Foster, PS | 1 |
| Furuya, E; Inoue, T; Nishida, T; Tagawa, K; Yamada, T | 1 |
| Cooper, CL; Malik, KU; Shaffer, JE | 1 |
| Hotchkiss, RS; Karl, IE; Lappas, GD; Osborne, DF | 1 |
| Dehpour, AR; Delfan, A; Ghafourifar, P; Rastegar, H; Samini, M | 1 |
| Chihara, K; Fukase, M; Kanatani, M; Kano, J; Kobayashi, T; Sugimoto, T; Yamaguchi, T | 1 |
| Conger, JD; Falk, SA; Robinette, JB | 1 |
| Fan, J; Frost, RA; Gelato, MC; Hoimes, ML; Lang, CH; Samstein, B | 1 |
| Hensel, M; Kox, WJ; Mäding, K; Volk, T | 1 |
| Giroir, B; Horton, JW; Maass, D; Sanders, B; Thompson, M; White, DJ | 1 |
| Horton, JW; Maass, DL; Sanders, B; White, DJ | 1 |
| Barclay, JK; Murrant, CL; Reading, SA | 1 |
| Casthely, PA; Lamprou, M; Yoganathan, T | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for diltiazem and dantrolene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for diltiazem and dantrolene
| Article | Year |
|---|---|
The mode of action of contractile effects induced by external calcium and its related bivalent cations in the KCl-depolarized rat uterus.
Topics: Animals; Barium; Calcium; Cations, Divalent; Dantrolene; Diltiazem; Edetic Acid; Egtazic Acid; Female; In Vitro Techniques; Manganese; Potassium Chloride; Rats; Strontium; Uterine Contraction | 1978 |
Inhibition of human mesangial cell proliferation by calcium channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium Channel Blockers; Cell Division; Cells, Cultured; Dantrolene; Diltiazem; Glomerular Mesangium; Humans; Nifedipine; Platelet-Derived Growth Factor; Thrombin; Thymidine; Verapamil | 1990 |
Characterization of high-affinity ryanodine-binding sites of rat liver endoplasmic reticulum. Differences between liver and skeletal muscle.
Topics: Animals; Base Sequence; Caffeine; Cells, Cultured; Dantrolene; Diltiazem; Endoplasmic Reticulum; Hydrogen-Ion Concentration; Kinetics; Liver; Male; Microsomes, Liver; Molecular Sequence Data; Muscles; Oligonucleotide Probes; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sodium Chloride | 1991 |
Effect of diltiazem, verapamil and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible human skeletal muscle.
Topics: Caffeine; Dantrolene; Diltiazem; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Potassium Chloride; Verapamil | 1989 |
Effect of diltiazem and dantrolene on the contractility of isolated malignant hyperpyrexia-susceptible porcine skeletal muscle.
Topics: Animals; Caffeine; Dantrolene; Diltiazem; Dose-Response Relationship, Drug; Halothane; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Potassium Chloride; Swine | 1989 |
Hepatic accumulation of pyrophosphate during acetate metabolism.
Topics: Acetates; Animals; Calcium; Dantrolene; Diltiazem; Diphosphates; Glucagon; Ketone Bodies; Liver; Male; Norepinephrine; Perfusion; Rats; Rats, Inbred Strains | 1988 |
Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Bradykinin; Calcimycin; Calcium; Calcium Channel Blockers; Calmodulin; Dantrolene; Diltiazem; Dinoprostone; Gallic Acid; Imidazoles; Indomethacin; Kidney; Male; Nicotinic Acids; Nimodipine; Prostaglandins E; Quinacrine; Rats; Rats, Inbred Strains; Ryanodine; Stimulation, Chemical; Sulfonamides; Trifluoperazine; Vasoconstriction | 1985 |
Calcium antagonists decrease plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin.
Topics: Animals; Biological Transport; Calcium; Cell Compartmentation; Dantrolene; Diltiazem; Endotoxins; Female; Imidazoles; Interleukin-1; Lipopolysaccharides; Mice; Muscle, Skeletal; Oxazoles; Tumor Necrosis Factor-alpha; Viscera | 1995 |
Comparison of various calcium channel blockers on guinea-pig isolated common bile duct.
Topics: Animals; Calcium Channel Blockers; Common Bile Duct; Dantrolene; Diltiazem; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Nifedipine; Verapamil | 1994 |
IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation.
Topics: 3T3 Cells; Animals; Antibodies; Calcium; Calcium Channel Blockers; Cell Division; Clone Cells; Cycloheximide; Dantrolene; Diltiazem; DNA; Dose-Response Relationship, Drug; Insulin-Like Growth Factor I; Kinetics; Magnesium; Mice; Nifedipine; Osteoblasts; Receptor, IGF Type 1; Transcription, Genetic; Verapamil | 1994 |
Angiotensin II-induced changes in smooth muscle calcium in rat renal arterioles.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Calcium; Culture Media; Dantrolene; Diltiazem; Egtazic Acid; Intracellular Membranes; Muscle, Smooth, Vascular; Rats; Renal Circulation; Vasoconstriction | 1993 |
IL-6 stimulation of insulin-like growth factor binding protein (IGFBP)-1 production.
Topics: Animals; Cell Line; Dantrolene; Diltiazem; Dose-Response Relationship, Drug; Endotoxins; Humans; Insulin-Like Growth Factor Binding Protein 1; Interleukin-6; Kinetics; Male; Mice; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Nitric oxide induces transient Ca2+ changes in endothelial cells independent of cGMP.
Topics: Adenosine Triphosphate; Caffeine; Calcium; Cell Line; Cyclic GMP; Dantrolene; Diltiazem; Endothelium, Vascular; Enzyme Activation; Guanylate Cyclase; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Nitric Oxide; Nitroprusside; Penicillamine; Procaine; Ryanodine; S-Nitroso-N-Acetylpenicillamine; Thapsigargin | 1997 |
Calcium antagonists improve cardiac mechanical performance after thermal trauma.
Topics: Animals; Burns; Calcium; Dantrolene; Diltiazem; Guinea Pigs; Hemodynamics; Myocardial Contraction; Myocardium; Sarcolemma | 1999 |
Cardiomyocyte intracellular calcium and cardiac dysfunction after burn trauma.
Topics: Amiloride; Amlodipine; Animals; Burns; Calcium; Calcium Channel Blockers; Dantrolene; Diltiazem; Myocardial Contraction; Myocardium; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium; Tumor Necrosis Factor-alpha; Ventricular Function, Left | 2002 |
Increased cAMP as a positive inotropic factor for mammalian skeletal muscle in vitro.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-Agonists; Animals; Bucladesine; Caffeine; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP; Dantrolene; Diltiazem; In Vitro Techniques; Isometric Contraction; Isoproterenol; Male; Mice; Muscle Relaxants, Central; Muscle, Skeletal; Sarcolemma; Sarcoplasmic Reticulum; Time Factors | 2003 |
Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Artery Bypass; Coronary Artery Disease; Dantrolene; Diltiazem; Diuretics; Drug Synergism; Furosemide; Glucose; Humans; Hyperkalemia; Hypoglycemic Agents; Insulin; Male; Malignant Hyperthermia; Metoprolol; Muscle Relaxants, Central; Potassium; Pulmonary Wedge Pressure | 1988 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |